跳至主要内容
临床试验/NCT05645185
NCT05645185已完成不适用

Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
Rankin score

研究概览

简要总结

Paraneoplastic neurological syndromes (PNS) are rare complications of cancer occurring in 0.01% of cases. Their clinical, biological and radiological presentation is heterogeneous and may constitute a diagnostic challenge. Anti-Ma2 PNS are rare diseases with a guarded prognosis. They are most often associated with a seminoma-like testicular tumor but can also be associated with lung cancer. Classically, they present as limbic, diencephalic and/or brainstem encephalitis. Anti-Ma2 antibodies target intracellular receptors and are characteristic of a particular form of encephalitis. Atypical manifestations including narcolepsy-cataplexy, weight gain, sexual dysfunction and motor neuron syndrome have been described and explain the difficulty in diagnosing anti-Ma2 associated PNS. It seems interesting to better characterize the phenotypes of Ma2 patients in order to optimize the diagnosis and follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Neurological disorder
  • Anti-Ma2 positivity in sera or CSF
  • Patient > 18 years old

排除标准

  • Patient without clinical data
  • Patient without Ma2 antibody in sera or CSF

结局指标

主要结局

Rankin score

时间窗: 12 month after diagnosis

Follow up and survival (rankin score)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验